Sec. 1003.051.  DEFINITIONS.  In this subchapter:
(1)  "Investigational stem cell treatment" means an adult stem cell treatment that:
(A)  is under investigation in a clinical trial and being administered to human participants in that trial; and
(B)  has not yet been approved for general use by the United States Food and Drug Administration.
(2)  "Severe chronic disease" means a condition, injury, or illness that:
(A)  may be treated;
(B)  is never cured or eliminated; and
(C)  entails significant functional impairment or severe pain.
(3)  "Terminal illness" means an advanced stage of a disease with an unfavorable prognosis that, without life-sustaining procedures, will soon result in death or a state of permanent unconsciousness from which recovery is unlikely.
Added by Acts 2017, 85th Leg., R.S., Ch. 697 (H.B. 810), Sec. 3, eff. September 1, 2017.